Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. [electronic resource]
Producer: 20150312Description: 27-38 p. digitalISSN:- 1558-3597
- Aged
- Antithrombins -- adverse effects
- Drug Therapy, Combination
- Female
- Heparin -- therapeutic use
- Hirudins -- adverse effects
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Peptide Fragments -- adverse effects
- Percutaneous Coronary Intervention
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.